Health Care & Life Sciences » Pharmaceuticals | Beijing Saisheng Pharmaceutical Co. Ltd.

Beijing Saisheng Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
160,788.90
-
209,228.70
258,346.70
281,531.40
283,161.50
Depreciation, Depletion & Amortization
-
-
17,827.50
18,619.50
18,235.50
22,753.90
Other Funds
640.00
630.00
1,084,844.70
-
-
15,448.40
Funds from Operations
196,824.10
214,225.10
227,583.80
278,960.00
306,725.60
318,126.80
Changes in Working Capital
-
-
34,511.70
14,329.60
149,973.20
124,152.40
Net Operating Cash Flow
196,824.10
214,225.10
193,072.10
264,630.40
156,752.40
193,974.50
Capital Expenditures
19,422.30
9,046.60
31,652.80
147,001.20
141,253.60
Sale of Fixed Assets & Businesses
-
-
13.70
313.80
171.60
Purchase/Sale of Investments
-
-
-
70,000.00
22,000.00
Net Investing Cash Flow
19,422.30
7,046.60
706,639.10
181,687.50
338,918.00
Cash Dividends Paid - Total
27,000.00
49,500.00
54,000.00
43,200.00
60,000.00
Net Financing Cash Flow
27,640.00
50,130.00
1,030,844.70
43,200.00
60,000.00
Net Change in Cash
149,761.80
157,048.50
517,277.70
39,742.90
435,670.50
Free Cash Flow
177,401.80
205,178.50
161,419.30
117,629.10
15,498.90
Deferred Taxes & Investment Tax Credit
-
-
49.20
135.60
388.80
3,236.90
Net Assets from Acquisitions
-
-
105,000.00
105,000.00
-
Other Sources
-
2,000.00
5,000.00
-
8,047,000.00
Other Uses
-
-
575,000.00
-
7,545,000.00

About Beijing Saisheng Pharmaceutical Co.

View Profile
Address
No. 8, Xinsheng Street
Beijing Beijing 100176
China
Employees -
Website http://www.ssyy.com.cn
Updated 07/08/2019
Beijing Science Sun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of bio-pharmaceutical products. It offers cardiovascular, immunology, nervous system, and all natural biological drugs. The company was founded on May 20, 1999 and is headquartered in Beijing, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.